Total planned funding: $165,812,748
Allocations
Countries/Regions
Eswatini | $165,812,748 |
Organizational Types
NGO | $39,451,464 |
Unknown | $36,546,385 |
Private Contractor | $35,482,954 |
University | $23,622,629 |
Own Agency | $19,614,286 |
Host Country Government Agency | $4,093,560 |
Multi-lateral Agency | $3,230,564 |
Other USG Agency | $2,978,406 |
FBO | $742,500 |
Implementing Agency | $50,000 |
Program Areas
Care | $52,679,440 |
Prevention | $34,324,152 |
Treatment | $29,485,030 |
Governance and Systems | $25,907,059 |
Testing | $11,958,531 |
Management and Operations | $11,458,536 |
Budget Codes
HTXS: Treatment: Adult Treatment | $23,463,049 |
HBHC: Care: Adult Care and Support | $22,636,133 |
HVSI: Strategic Information | $16,126,703 |
HKID: Care: Orphans and Vulnerable Children | $13,247,440 |
HVCT: Testing: HIV Testing and Counseling | $11,958,531 |
HVTB: Care: TB/HIV | $11,801,286 |
HVMS: Management and Operations | $11,458,536 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $10,929,422 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $9,695,459 |
HVOP: Sexual Prevention: Other Sexual Prevention | $8,767,955 |
OHSS: Health Systems Strengthening | $6,292,094 |
PDCS: Care: Pediatric Care and Support | $4,994,581 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $4,469,316 |
HLAB: Laboratory Infrastructure | $3,488,262 |
HTXD: Treatment: ARV Drugs | $3,039,187 |
PDTX: Treatment: Pediatric Treatment | $2,982,794 |
HMBL: Biomedical Prevention: Blood Safety | $462,000 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$36,396,385
Countries/Regions
Columbia University:
$19,222,238
Countries/Regions
Pact, Inc.:
$18,398,396
Countries/Regions
USG Aggregated Agencies:
$12,416,763
Countries/Regions